Biogen inks autoimmune deal with Mitsubhishi Tanabe pharma

Singapore: US-based Biogen, a leading developer of therapies for neurodegenerative diseases has inked a pact with Japan'...

September 11, 2015 | Friday | News
Janssen seeks approval for drug resistant TB drug in EU

Singapore: Janssen-Cilag International NV (Janssen) submitted a marketing authorization application to the European Medi...

September 4, 2012 | Tuesday | Regulatory
Thailand develops its first-ever indigenous drug

Singapore: Thailand's former science and technology (S&T) minister, Professor Yongyuth Yuthavong, and his team have ...

December 26, 2012 | Wednesday | News
J&J starts clinical trial of Ebola vaccine in Sierra Leone

Johnson & Johnson (J&J) has announced the start of a safety and immunogenicity clinical trial in Sierra Leone of...

October 12, 2015 | Monday | News
ASLAN's bile duct cancer drug receives orphan drug status

Singapore: Singapore's ASLAN pharmaceuticals recently announced that the Food and Drug Administration (FDA) has granted ...

August 21, 2015 | Friday | News
TaiGen initiates clinical trial of leukemia drug in China

Singapore: Taiwan's TaiGen Biotechnology has initiated first burixafor trial for relapsed or refractory acute myeloid le...

May 4, 2015 | Monday | News
China approves Bayer's Xarelto

Singapore: Bayer's anticoagulant drug, Xarelto (rivaroxaban), has been approved by the China Food and Drug Administratio...

May 5, 2015 | Tuesday | News
ScinoPharm, Foresee form joint venture

Singapore: Taiwanese company ScinoPharm and US-based Foresee Pharmaceuticals have signed an investment agreement to form...

February 1, 2013 | Friday | News
Novogen's drug shows positive result for brain cancer

Singapore: Australian biotechnology company, Novogen's lead candidate product, TRXE-009, has shown a positive result in ...

March 5, 2015 | Thursday | News
Phosphagenics achieves biggest milestone yet

Singapore: Australian drug delivery technology company, Phosphagenics has achieved succes in its multi-dose oxymorphone ...

October 29, 2013 | Tuesday | News
Aussie firm trials combination therapy for melanoma

Singapore: Australia based Viralytics has initiated a clinical trial to assess its oncolytic virus, Cavatak, in combinat...

September 29, 2015 | Tuesday | News
Aussie chemotherapy drug gets orphan designation

Singappore: US Food and Drug Administration (FDA) has granted orphan drug designation to chemotherapy drug candidate Can...

April 23, 2015 | Thursday | News
Eisai submits Lenvatinib's new application in Europe

Tokyo: Japan's pharma giant Eisai Co Ltd announced that its European regional headquarters Eisai Europe Ltd has submitte...

January 13, 2016 | Wednesday | News
Baxter expands oncology pipeline through acquisition

Singapore: Baxter has acquired Oncaspar (pegaspargase) product portfolio, a first-line biologic used as part of a multi-...

May 13, 2015 | Wednesday | News
Prana completes phase II trial with PBT2

Singapore: Prana Biotechnology announced the successful completion of Reach2HD, a phase II clinical trial in patients wi...

July 24, 2013 | Wednesday | News
Clue to future universal dengue vaccine found

Singapore: Scientists at A*Star's Singapore Immunology Network (SIgN) have discovered a clue that has the potential to c...

August 14, 2013 | Wednesday | News
Lupin hires top Teva, Sandoz staff for R&D in US

Mumbai: Lupin is setting up a R&D center in the US, and has hired the R&D head of Teva Pharmaceuticals and other...

August 13, 2013 | Tuesday | News
Janssen terminates R&D alliance with Hutchison Medipharma

Singapore: Janssen Pharmaceutical has terminated the research and development alliance with China based Hutchison Mediph...

August 26, 2015 | Wednesday | News